Lord, Abbett & Co »

Arrowhead Pharmaceuticals In Note 1/1 shares owned by Lord, Abbett & Co

Quarter-by-quarter ownership of Arrowhead Pharmaceuticals In Note 1/1 shares owned by Lord, Abbett & Co from 13F filings

Historical chart of Lord, Abbett & Co investment in Arrowhead Pharmaceuticals In Note 1/1

Tip: Access up to 7 years of quarterly data

All positions including Arrowhead Pharmaceuticals In Note 1/1 held by Lord, Abbett & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrowhead Pharmaceuticals In Note 1/1 by Lord, Abbett & Co

Quarter filed Position value Share count Share price at filing
2026-06-30 $8.7M 7.3M 1.19

More positions owned by Lord, Abbett & Co

NVIDIA Corporation (NVDA)
Alphabet Inc Class A cs (GOOGL)
Lam Research (LRCX)
Broadcom (AVGO)
Taiwan Semiconductor Mfg (TSM)
JPMorgan Chase & Co. (JPM)
Eli Lilly & Co. (LLY)
Apple (AAPL)
Microsoft Corporation (MSFT)
Morgan Stanley (MS)
Comfort Systems USA (FIX)
UnitedHealth (UNH)
Analog Devices (ADI)
Parker-Hannifin Corporation (PH)
Johnson & Johnson (JNJ)

View all positions for Lord, Abbett & Co

Top funds holding Arrowhead Pharmaceuticals In Note 1/1

Deerfield Management Company
Camden Asset Management
LMR Partners
Linden Advisors
Ubs Global Asset Management Americas
Readystate Asset Management
Lazard Asset Management
Calamos Advisors
MacKay Shields
DeepCurrents Investment Group
Context Capital Management
Advent Capital Management
State Street Corporation
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Oaktree Capital Management

View all funds holding Arrowhead Pharmaceuticals In Note 1/1